Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386308 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of XP12B in Women With Menorrhagia
A Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 196
- Enrollment target
- 20
- Study locations
NCT00386308 is a Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 196 participants, roughly in line with the 209-participant average among 10 other Menorrhagia trials with a reported enrollment target. The trial reports 20 study locations across 9 states.
The verdict
NCT00386308, a Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 196 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Conditions Studied
Interventions
- DRUG Tranexamic acid tablets
- DRUG Placebo tablets
Study Locations (20)
Georgia
- Investigative Site - Atlanta
- Investigative Site - Atlanta
- Investigative Site - Decatur
- Investigative Site - Savannah
California
- Investigative Site - Carmichael
- Investigative Site - San Diego
- Investigative Site - Upland
Florida
- Investigative Site - Inverness
- Investigative Site - Miami
- Investigative Site - Miami
Arizona
- Investigative Site - Tucson
- Investigative Site - Tucson
Colorado
- Investigative Site - Denver
- Investigative Site - Lakewood
Connecticut
- Investigative Site - Groton
- Investigative Site - West Hartford
Louisiana
- Investigative Site - Amite
- Investigative Site - Baton Rouge
Arkansas
- Investigative Site - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386308
The ClinicalTrials.gov registry entry for NCT00386308 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 209-participant average among 10 other Menorrhagia trials with a reported enrollment target. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Menorrhagia appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic acid tablets is the first listed.
NCT00386308 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Georgia, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00386308 about?
NCT00386308 is a clinical study titled "Efficacy and Safety Study of XP12B in Women With Menorrhagia". The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
What is the current status of trial NCT00386308?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 196 participants. The study started on 2006-10. Estimated completion is 2008-05.
What conditions does trial NCT00386308 study?
This clinical trial studies the following conditions: Menorrhagia, Heavy Menstrual Bleeding.
What interventions are being tested in trial NCT00386308?
The interventions under investigation include: Tranexamic acid tablets (DRUG), Placebo tablets (DRUG).
Who is sponsoring clinical trial NCT00386308?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00386308 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
COMPLETED · Phase 3
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
COMPLETED · Phase 3
-
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
RECRUITING
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
COMPLETED
-
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.